| Identification | More | [Name]
5-(Trifluoromethyl)pyridin-2-amine | [CAS]
74784-70-6 | [Synonyms]
2-AMINO-5-(TRIFLUOROMETHYL)PYRIDINE
5-(TRIFLUOROMETHYL)-2-PYRIDINAMINE
5-(TRIFLUOROMETHYL)PYRIDIN-2-AMINE
5-TRIFLUOROMETHYL-PYRIDIN-2-YLAMINE
BUTTPARK 43\57-47
TIMTEC-BB SBB005500
2-Amino-5-trifuoromethylpyridine
2-Amino-5-(trifluoromethyl)pyridine 95%
2-Amino-5-(trifluoromethyl)pyridine95%
2-pyridinamine,5-(triflluoromethyl
2-Amine-5-Trifluromethyl Pyridine
5-(Trifluoromethyl)pyridin-2-amine ,97% | [EINECS(EC#)]
623-444-2 | [Molecular Formula]
C6H5F3N2 | [MDL Number]
MFCD00042164 | [Molecular Weight]
162.11 | [MOL File]
74784-70-6.mol |
| Chemical Properties | Back Directory | [Melting point ]
45 °C | [Boiling point ]
90-92/20mbar | [density ]
1,71g/cm | [refractive index ]
1,533 | [Fp ]
104 °C | [storage temp. ]
Keep in dark place,Inert atmosphere,2-8°C | [solubility ]
Chloroform (Slightly), Methanol (Slightly) | [form ]
Solid | [pka]
4.55±0.13(Predicted) | [color ]
Off-White | [Detection Methods]
HPLC,NMR | [BRN ]
4800784 | [InChIKey]
RSGVKIIEIXOMPY-UHFFFAOYSA-N | [CAS DataBase Reference]
74784-70-6(CAS DataBase Reference) |
| Safety Data | Back Directory | [Hazard Codes ]
Xn,Xi,T | [Risk Statements ]
R20/21/22:Harmful by inhalation, in contact with skin and if swallowed .
R36/37/38:Irritating to eyes, respiratory system and skin .
R25:Toxic if swallowed. | [Safety Statements ]
S26:In case of contact with eyes, rinse immediately with plenty of water and seek medical advice .
S36/37/39:Wear suitable protective clothing, gloves and eye/face protection .
S45:In case of accident or if you feel unwell, seek medical advice immediately (show label where possible) .
S36:Wear suitable protective clothing . | [RIDADR ]
UN 2811 6.1/PG 3 | [WGK Germany ]
3 | [Hazard Note ]
Irritant | [HazardClass ]
6.1 | [HazardClass ]
IRRITANT | [PackingGroup ]
III | [HS Code ]
29333990 |
| Hazard Information | Back Directory | [Chemical Properties]
White to brown solid | [Uses]
2-?Amino-?5-?(trifluoromethyl)? is a reagent used in the synthesis of selective inhibitors of urokinase plasminogen activator in a non-cytotoxic form of cancer therapy. |
|
|